Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells
This study has been withdrawn prior to enrollment.
( New safety information reported in the post-marketing setting with efalizumab for treatment of chronic plaque psoriasis and trial conduct feasibility issues. )
Study NCT00777400   Information provided by University of California, San Francisco

First Received on October 20, 2008.   Last Updated on May 13, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial